| necroptotic process | GO:0070266 | 21 | 0.765 | |
| necrotic cell death | GO:0070265 | 30 | 0.550 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.485 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.485 | Human |
| regulation of necroptotic process | GO:0060544 | 10 | 0.483 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.475 | |
| negative regulation of necrotic cell death | GO:0060547 | 11 | 0.386 | |
| necroptotic signaling pathway | GO:0097527 | 3 | 0.380 | Human |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.378 | |
| t cell extravasation | GO:0072683 | 4 | 0.374 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.371 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.359 | |
| programmed necrotic cell death | GO:0097300 | 28 | 0.357 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.355 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.320 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.316 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.299 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.286 | |
| t cell proliferation | GO:0042098 | 120 | 0.279 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.262 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.258 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.256 | Human |
| homeostasis of number of cells | GO:0048872 | 210 | 0.246 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.244 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.238 | |
| positive regulation of macrophage differentiation | GO:0045651 | 5 | 0.236 | Human |
| myeloid cell differentiation | GO:0030099 | 233 | 0.236 | Human |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.228 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.228 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.221 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.221 | Human |
| leukocyte proliferation | GO:0070661 | 172 | 0.217 | |
| regulation of secretion | GO:0051046 | 274 | 0.209 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.208 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.206 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.185 | |
| protein processing | GO:0016485 | 163 | 0.184 | Human |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.181 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.174 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.169 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.168 | |
| mitochondrion organization | GO:0007005 | 134 | 0.165 | |
| activation induced cell death of t cells | GO:0006924 | 10 | 0.162 | |
| t cell homeostasis | GO:0043029 | 35 | 0.161 | |
| regulation of b cell proliferation | GO:0030888 | 39 | 0.156 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.155 | |
| defense response to bacterium | GO:0042742 | 119 | 0.155 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.154 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.153 | |
| zymogen activation | GO:0031638 | 41 | 0.153 | Human |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.152 | Human |
| regulation of interleukin 1 alpha production | GO:0032650 | 4 | 0.150 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.146 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.144 | Human |
| t cell apoptotic process | GO:0070231 | 39 | 0.143 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.141 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.139 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.133 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.129 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.129 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 27 | 0.127 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.127 | |
| regulation of defense response | GO:0031347 | 233 | 0.125 | Human |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.125 | Human |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.124 | Human |
| dna metabolic process | GO:0006259 | 303 | 0.123 | |
| immune effector process | GO:0002252 | 321 | 0.121 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.120 | Human |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.119 | |
| regulation of cell activation | GO:0050865 | 289 | 0.118 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.117 | |
| cellular response to peptidoglycan | GO:0071224 | 4 | 0.112 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.112 | Human |
| cytokine production | GO:0001816 | 319 | 0.109 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.109 | |
| positive regulation of interleukin 1 alpha production | GO:0032730 | 4 | 0.105 | |
| defense response to other organism | GO:0098542 | 197 | 0.104 | Human |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.104 | Human |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.104 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.103 | |
| regulation of necrotic cell death | GO:0010939 | 13 | 0.103 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.100 | |
| cellular response to lipid | GO:0071396 | 145 | 0.100 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.099 | Human |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.098 | |
| regulation of protein transport | GO:0051223 | 163 | 0.095 | |
| interleukin 1 alpha secretion | GO:0050703 | 3 | 0.093 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.092 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.092 | |
| jnk cascade | GO:0007254 | 72 | 0.091 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.090 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.089 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.088 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.088 | |
| regulation of macrophage differentiation | GO:0045649 | 9 | 0.086 | Human |
| negative regulation of b cell activation | GO:0050869 | 27 | 0.084 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.083 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.082 | |
| toll like receptor signaling pathway | GO:0002224 | 38 | 0.082 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.081 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.081 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.081 | |
| protein secretion | GO:0009306 | 111 | 0.080 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.079 | Human |
| cd8 positive alpha beta t cell extravasation | GO:0035697 | 3 | 0.078 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.078 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.078 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.078 | Human |
| cytokine secretion | GO:0050663 | 72 | 0.076 | |
| positive regulation of immature t cell proliferation | GO:0033091 | 4 | 0.076 | |
| organelle assembly | GO:0070925 | 177 | 0.076 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.075 | |
| protein catabolic process | GO:0030163 | 221 | 0.074 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.074 | |
| regulation of interleukin 1 alpha secretion | GO:0050705 | 3 | 0.074 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.073 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.073 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.073 | |
| skin development | GO:0043588 | 220 | 0.073 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.070 | |
| positive regulation of interleukin 6 production | GO:0032755 | 37 | 0.069 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.069 | Human |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.068 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.068 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.067 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.067 | Human |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.067 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.066 | |
| protein maturation | GO:0051604 | 176 | 0.066 | Human |
| positive regulation of interleukin 1 secretion | GO:0050716 | 14 | 0.065 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.065 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.064 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.064 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.063 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.063 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.063 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.062 | |
| lymph node development | GO:0048535 | 18 | 0.061 | |
| signal transduction involved in dna damage checkpoint | GO:0072422 | 3 | 0.061 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.061 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.061 | |
| t cell activation | GO:0042110 | 289 | 0.061 | |
| regulation of cd8 positive alpha beta t cell extravasation | GO:2000449 | 3 | 0.061 | |
| epidermis development | GO:0008544 | 187 | 0.060 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.059 | |
| negative regulation of b cell proliferation | GO:0030889 | 13 | 0.059 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.058 | Human |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.058 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.058 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.058 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.058 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.058 | Human |
| regulation of t cell mediated cytotoxicity | GO:0001914 | 18 | 0.057 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.057 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.057 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.057 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.057 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.057 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.056 | |
| regulation of protein localization | GO:0032880 | 231 | 0.056 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.055 | Human |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.055 | |
| interleukin 6 production | GO:0032635 | 58 | 0.055 | |
| positive regulation of interleukin 1 alpha secretion | GO:0050717 | 3 | 0.054 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.054 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.054 | |
| regulation of cell motility | GO:2000145 | 236 | 0.054 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.054 | |
| positive regulation of interferon gamma production | GO:0032729 | 39 | 0.053 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.053 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.053 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.053 | |
| ripoptosome assembly involved in necroptotic process | GO:1901026 | 6 | 0.053 | |
| negative regulation of cyclin dependent protein serine threonine kinase activity | GO:0045736 | 9 | 0.052 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.052 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.052 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.051 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.051 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.050 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.050 | |
| regulation of t cell extravasation | GO:2000407 | 3 | 0.050 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.050 | Human |
| interferon gamma production | GO:0032609 | 67 | 0.049 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.049 | |
| membrane hyperpolarization | GO:0060081 | 21 | 0.048 | |
| interleukin 8 production | GO:0032637 | 4 | 0.048 | Human |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.048 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.047 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.047 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.046 | |
| b cell activation | GO:0042113 | 161 | 0.046 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.045 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.045 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.045 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.045 | |
| regulation of mitochondrial membrane potential | GO:0051881 | 17 | 0.045 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.044 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.044 | |
| response to hypoxia | GO:0001666 | 58 | 0.044 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.044 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.044 | |
| thymus development | GO:0048538 | 41 | 0.043 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.043 | |
| spleen development | GO:0048536 | 39 | 0.043 | |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 25 | 0.043 | |
| cellular response to topologically incorrect protein | GO:0035967 | 25 | 0.043 | |
| b cell proliferation | GO:0042100 | 53 | 0.042 | |
| dna repair | GO:0006281 | 107 | 0.042 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.042 | Human |
| tube formation | GO:0035148 | 140 | 0.041 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.041 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.041 | |
| compound eye development | GO:0048749 | 1 | 0.041 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.041 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.040 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.040 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.040 | |
| response to organophosphorus | GO:0046683 | 22 | 0.040 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.040 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.040 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.039 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.039 | |
| positive regulation of t helper 1 cell differentiation | GO:0045627 | 4 | 0.039 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.039 | Human |
| response to oxidative stress | GO:0006979 | 123 | 0.039 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.039 | |
| sensory perception of sound | GO:0007605 | 97 | 0.038 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.038 | Human |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.038 | |
| toll like receptor 4 signaling pathway | GO:0034142 | 9 | 0.038 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.038 | |
| negative regulation of necroptotic process | GO:0060546 | 9 | 0.037 | |
| macrophage differentiation | GO:0030225 | 20 | 0.037 | Human |
| membrane depolarization | GO:0051899 | 64 | 0.037 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.037 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.037 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.037 | Human |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.037 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.036 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.036 | |
| protein deacetylation | GO:0006476 | 32 | 0.036 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.036 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.036 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.036 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.036 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.035 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.035 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.035 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.035 | |
| regulation of cell killing | GO:0031341 | 40 | 0.035 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.034 | |
| alpha beta t cell proliferation | GO:0046633 | 21 | 0.034 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.034 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.034 | |
| activation of immune response | GO:0002253 | 138 | 0.034 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.034 | |
| interleukin 1 beta secretion | GO:0050702 | 16 | 0.034 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.034 | |
| innate immune response | GO:0045087 | 157 | 0.033 | Human |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.033 | |
| cd8 positive alpha beta cytotoxic t cell extravasation | GO:0035698 | 2 | 0.033 | |
| response to dsrna | GO:0043331 | 30 | 0.033 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.033 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.033 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.033 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.033 | |
| microtubule based process | GO:0007017 | 236 | 0.033 | |
| inflammatory response | GO:0006954 | 244 | 0.033 | |
| response to atp | GO:0033198 | 8 | 0.033 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.033 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.033 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 25 | 0.032 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.032 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.032 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.031 | |
| amine metabolic process | GO:0009308 | 45 | 0.031 | |
| dna endoreduplication | GO:0042023 | 4 | 0.031 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.031 | |
| protein oligomerization | GO:0051259 | 67 | 0.031 | |
| angiogenesis | GO:0001525 | 201 | 0.031 | |
| response to uv | GO:0009411 | 44 | 0.031 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.031 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.031 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.031 | |
| epithelial tube formation | GO:0072175 | 130 | 0.030 | |
| interleukin 1 production | GO:0032612 | 31 | 0.030 | |
| cellular homeostasis | GO:0019725 | 240 | 0.030 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.030 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.029 | |
| gland development | GO:0048732 | 330 | 0.029 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.029 | Human |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.029 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.029 | |
| interferon beta biosynthetic process | GO:0045350 | 4 | 0.029 | |
| response to radiation | GO:0009314 | 165 | 0.029 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.029 | |
| myotube differentiation | GO:0014902 | 105 | 0.029 | |
| sensory perception | GO:0007600 | 245 | 0.029 | |
| regulation of activated t cell proliferation | GO:0046006 | 16 | 0.028 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.028 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.028 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.028 | |
| protein homooligomerization | GO:0051260 | 43 | 0.028 | |
| cell killing | GO:0001906 | 67 | 0.028 | |
| mapk cascade | GO:0000165 | 281 | 0.028 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.028 | |
| regulation of ion transport | GO:0043269 | 215 | 0.028 | |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 30 | 0.028 | |
| positive regulation of t cell proliferation | GO:0042102 | 52 | 0.028 | |
| nucleotide binding oligomerization domain containing 1 signaling pathway | GO:0070427 | 5 | 0.028 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.027 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.027 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.027 | |
| dna catabolic process | GO:0006308 | 19 | 0.027 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.027 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.027 | Human |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.027 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.027 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.027 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.027 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.027 | |
| er nucleus signaling pathway | GO:0006984 | 27 | 0.027 | |
| immunoglobulin production | GO:0002377 | 73 | 0.026 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.026 | |
| autophagy | GO:0006914 | 45 | 0.026 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 16 | 0.026 | |
| hepatocyte apoptotic process | GO:0097284 | 11 | 0.026 | |
| regulation of apoptotic dna fragmentation | GO:1902510 | 5 | 0.026 | |
| regulation of interferon beta biosynthetic process | GO:0045357 | 4 | 0.026 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.026 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.026 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.026 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.025 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.025 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.025 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.025 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.025 | |
| transmembrane transport | GO:0055085 | 412 | 0.024 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.024 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.024 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.024 | |
| regulation of binding | GO:0051098 | 111 | 0.024 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.024 | |
| neuron death | GO:0070997 | 154 | 0.024 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.024 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.024 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.024 | |
| response to steroid hormone | GO:0048545 | 56 | 0.023 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.023 | |
| regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902041 | 22 | 0.023 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.023 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.023 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.023 | |
| regulation of t cell apoptotic process | GO:0070232 | 28 | 0.023 | |
| toxin transport | GO:1901998 | 38 | 0.023 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.023 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.023 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.022 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.022 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.022 | |
| positive regulation of alpha beta t cell differentiation | GO:0046638 | 28 | 0.022 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.022 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.022 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.022 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.022 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.022 | |
| mitochondrial depolarization | GO:0051882 | 6 | 0.022 | |
| response to tumor necrosis factor | GO:0034612 | 26 | 0.022 | |
| cation homeostasis | GO:0055080 | 212 | 0.022 | |
| protein deacylation | GO:0035601 | 36 | 0.022 | |
| interleukin 1 secretion | GO:0050701 | 16 | 0.022 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.022 | |
| nucleotide binding oligomerization domain containing signaling pathway | GO:0070423 | 6 | 0.022 | |
| interleukin 12 production | GO:0032615 | 32 | 0.022 | |
| response to growth factor | GO:0070848 | 198 | 0.021 | |
| protein localization to organelle | GO:0033365 | 185 | 0.021 | |
| regulation of neuron death | GO:1901214 | 134 | 0.021 | |
| regulation of cd4 positive alpha beta t cell activation | GO:2000514 | 24 | 0.021 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.021 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.021 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.021 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.021 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.021 | |
| negative regulation of signal transduction in absence of ligand | GO:1901099 | 16 | 0.021 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.021 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.021 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.021 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.021 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.021 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.020 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.020 | |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 3 | 0.020 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.020 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.020 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.020 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.020 | |
| response to lipoteichoic acid | GO:0070391 | 6 | 0.020 | |
| regulation of alpha beta t cell proliferation | GO:0046640 | 18 | 0.020 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.020 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.020 | |
| response to oxygen levels | GO:0070482 | 62 | 0.020 | |
| positive regulation of response to cytokine stimulus | GO:0060760 | 11 | 0.020 | Human |
| protein acylation | GO:0043543 | 64 | 0.020 | |
| thymocyte apoptotic process | GO:0070242 | 19 | 0.020 | |
| b cell homeostasis | GO:0001782 | 34 | 0.020 | |
| signal transduction involved in cell cycle checkpoint | GO:0072395 | 3 | 0.020 | |
| ossification | GO:0001503 | 216 | 0.020 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.019 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.019 | |
| signal transduction involved in mitotic dna integrity checkpoint | GO:1902403 | 3 | 0.019 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.019 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.019 | |
| regulation of cell migration | GO:0030334 | 219 | 0.019 | |
| response to acid chemical | GO:0001101 | 111 | 0.019 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.019 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.019 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.019 | |
| protein glycosylation | GO:0006486 | 55 | 0.019 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.019 | |
| exocytosis | GO:0006887 | 121 | 0.019 | |
| neural tube development | GO:0021915 | 160 | 0.019 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.019 | |
| endoplasmic reticulum unfolded protein response | GO:0030968 | 19 | 0.019 | |
| amide transport | GO:0042886 | 138 | 0.019 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.018 | |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.018 | |
| regulation of autophagy | GO:0010506 | 30 | 0.018 | |
| regulation of interleukin 1 secretion | GO:0050704 | 15 | 0.018 | |
| muscle tissue development | GO:0060537 | 308 | 0.018 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.018 | Human |
| cell cycle checkpoint | GO:0000075 | 47 | 0.018 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.018 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.018 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.018 | |
| type i interferon production | GO:0032606 | 29 | 0.018 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.018 | |
| signal transduction involved in mitotic cell cycle checkpoint | GO:0072413 | 3 | 0.018 | |
| adaptive immune response | GO:0002250 | 155 | 0.018 | |
| locomotory behavior | GO:0007626 | 195 | 0.018 | |
| regulation of thymocyte apoptotic process | GO:0070243 | 14 | 0.017 | |
| methylation | GO:0032259 | 134 | 0.017 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.017 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.017 | |
| dendrite development | GO:0016358 | 115 | 0.017 | |
| glycosylation | GO:0070085 | 62 | 0.017 | |
| regulation of cytokine production involved in immune response | GO:0002718 | 26 | 0.017 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.017 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.017 | |
| response to topologically incorrect protein | GO:0035966 | 25 | 0.017 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.017 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.017 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.017 | |
| male gamete generation | GO:0048232 | 285 | 0.017 | |
| regulation of t helper 1 cell differentiation | GO:0045625 | 7 | 0.017 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.017 | |
| response to unfolded protein | GO:0006986 | 21 | 0.017 | |
| positive regulation of interleukin 1 beta secretion | GO:0050718 | 14 | 0.017 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.017 | |
| cofactor transport | GO:0051181 | 4 | 0.017 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.017 | |
| leukocyte migration | GO:0050900 | 124 | 0.017 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.017 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.016 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.016 | |
| cell fate commitment | GO:0045165 | 210 | 0.016 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.016 | |
| ectopic germ cell programmed cell death | GO:0035234 | 9 | 0.016 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.016 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.016 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.016 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.016 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.016 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.016 | |
| response to interleukin 18 | GO:0070673 | 4 | 0.016 | |
| positive regulation of interleukin 12 production | GO:0032735 | 21 | 0.016 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.016 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.016 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.016 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.016 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.016 | Human |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.016 | |
